The NIH itself did another, earlier study on type 1 diabetes and reached the opposite conclusion of the ACCORD study.

The DCCT and EDIC studies showed that:

What is the EDIC?

When the DCCT ended in 1993, researchers continued to study more than 90 percent of participants. The follow-up study, called Epidemiology of Diabetes Interventions and Complications (EDIC), is assessing the incidence and predictors of cardiovascular disease events such as heart attack, stroke, or needed heart surgery, as well as diabetic complications related to the eye, kidney, and nerves. The EDIC study is also examining the impact of intensive control versus standard control on quality of life. Another objective is to look at the cost-effectiveness of intensive control.

DCCT Study Findings

Intensive blood glucose control reduces risk of

* eye disease
76% reduced risk
* kidney disease
50% reduced risk
* nerve disease
60% reduced risk

EDIC Study Findings

Intensive blood glucose control reduces risk of

* any cardiovascular disease event
42% reduced risk
* nonfatal heart attack, stroke, or death from cardiovascular causes
57% reduced risk

http://diabetes.niddk.nih.gov/dm/pubs/control/

The blood glucose lowering agent was simply insulin instead of the cocktails prescribed to Type 2s. IMO, insulin is the safest glucose lowering agent because Human insulin is the same as the insulin in your body.